Biomerica (NASDAQ:BMRA) Stock Passes Below 200-Day Moving Average of $0.86

Biomerica, Inc. (NASDAQ:BMRA) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.86 and traded as low as $0.43. Biomerica shares last traded at $0.44, with a volume of 49,424 shares.

Biomerica Stock Down 2.2 %

The company’s fifty day simple moving average is $0.58 and its 200-day simple moving average is $0.86.

Biomerica (NASDAQ:BMRA) last released its quarterly earnings results on Friday, April 12th. The company reported ($0.11) earnings per share (EPS) for the quarter. Biomerica had a negative return on equity of 64.00% and a negative net margin of 117.46%. The firm had revenue of $1.02 million during the quarter.

Institutional Investors Weigh In On Biomerica

An institutional investor recently raised its position in Biomerica stock. Fore Capital LLC increased its stake in shares of Biomerica, Inc. (NASDAQ:BMRA) by 72.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 59,680 shares of the company’s stock after buying an additional 25,000 shares during the quarter. Fore Capital LLC owned about 0.35% of Biomerica worth $50,000 as of its most recent SEC filing. 22.28% of the stock is currently owned by institutional investors and hedge funds.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.